Dentists in Stockton, IL Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. Caitlin M Pullara, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 W Front Ave, Stockton, IL 61085 Phone: 815-947-3700 Fax: 815-947-9058 |
 Dr. Stephen F Petras, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 120 W Front Ave, Stockton, IL 61085 Phone: 815-947-3700 Fax: 815-947-9058 |
News Archive
Toshiba introduces Aquilion ONE ViSION Edition
Hospitals will now be able to diagnose diseases faster and safer with Toshiba America Medical Systems, Inc.'s newest and most advanced CT system yet, the AquilionTM ONE ViSION Edition. The system offers a low dose exam with the largest bore, widest coverage and thinnest slices.
UCSF neuroscientist wins PECASE award for research into addiction
Linda Wilbrecht, PhD, a neuroscientist at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco (UCSF), is one of 94 researchers named today by President Obama as a recipient of the Presidential Early Career Awards for Scientists and Engineers (PECASE).
Clinical trials activity of Synexus in Hungary increases 25% in first-half of 2010
Synexus clinical trials activity in Hungary has increased by 25% during the first half of 2010. The company's Dedicated Research Centre has been operating in Hungary since 2006 and has become one of the company's most successful CEE sites. The Budapest-based operation has been involved in excess of 74 trials since being acquired by Synexus, and randomized over 600 patients.
Chemical biology researchers to meet at Scientific Oktoberfest in München
The "Scientific Oktoberfest" will be this year's meeting point for some of the internationally most distinguished researchers in the field of Chemical Biology. The so-called "CIPSM Fest of Chemical Biology" will be held from the 15th to the 16th of September in the Department of Chemistry of the Ludwig-Maximilians-Universität (LMU) München.
Genentech disappointed with FDA ODAC's recommendation against Avastin
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
› Verified 1 days ago